Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma (Q89811611)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

title

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

head and neck squamous cell carcinoma

8 April 2020

main subject

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

author name string

Linda Tran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Clint T Allen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Ellen Moore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Ruth Davis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

So-Jin Park

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Katie Spielbauer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Carter Van Waes

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Nicole C Schmitt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

publication date

2 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology Research

8 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

page(s)

1141-1151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.

8 April 2020

cites work

1 reference

12 December 2020

Immune checkpoint blockade: a common denominator approach to cancer therapy

1 reference

12 December 2020

Combination immunotherapy: a road map.

1 reference

12 December 2020

Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers

1 reference

12 December 2020

mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer

1 reference

12 December 2020

Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics.

1 reference

12 December 2020

Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses

1 reference

12 December 2020

STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients

1 reference

12 December 2020

Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells.

1 reference

12 December 2020

Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence

1 reference

12 December 2020

Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ.

1 reference

12 December 2020

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

1 reference

12 December 2020

Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer

1 reference

12 December 2020

Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.

1 reference

12 December 2020

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

1 reference

12 December 2020

Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines

1 reference

12 December 2020

PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model

1 reference

12 December 2020

5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers

1 reference

12 December 2020

Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer

1 reference

12 December 2020

Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease

1 reference

12 December 2020

P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.

1 reference

12 December 2020

The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines

1 reference

12 December 2020

Immunology and Immunotherapy of Head and Neck Cancer

1 reference

12 December 2020

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

1 reference

12 December 2020

Sound preconditioning therapy inhibits ototoxic hearing loss in mice

1 reference

12 December 2020

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin

1 reference

12 December 2020

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

1 reference

12 December 2020

Celastrol inhibits aminoglycoside-induced ototoxicity via heat shock protein 32.

1 reference

12 December 2020

Comprehensive genomic characterization of head and neck squamous cell carcinomas

1 reference

12 December 2020

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

1 reference

12 December 2020

p53 induces TAP1 and enhances the transport of MHC class I peptides

1 reference

12 December 2020

Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer

1 reference

12 December 2020

Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.

1 reference

12 December 2020

Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes

1 reference

12 December 2020

Osteopontin does not mitigate cisplatin ototoxicity or nephrotoxicity in adult mice

1 reference

12 December 2020

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

1 reference

12 December 2020

Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma

1 reference

12 December 2020

Pools of programmed death-ligand within the oral cavity tumor microenvironment: Variable alteration by targeted therapies

1 reference

12 December 2020

Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade.

1 reference

12 December 2020

Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience.

1 reference

12 December 2020

Immunosurveillance and therapy of multiple myeloma are CD226 dependent

1 reference

12 December 2020

STAT1 Activation Is Enhanced by Cisplatin and Variably Affected by EGFR Inhibition in HNSCC Cells

1 reference

12 December 2020

Anticancer metal drugs and immunogenic cell death.

1 reference

12 December 2020

10.1158/2326-6066.CIR-17-0235

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29097421%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

1 reference